Tech Company Financing Transactions

AN2 Therapeutics Funding Round

Mountain Group Capital, Adjuvant Capital and BioRock Ventures invested in a $12 million Series A funding round for AN2 Therapeutics. The financing round closed on 11/26/2019.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

171 Forest Ln.
Menlo Park, CA 94025
USA

Phone

(650) 838-0859

Website

www.an2therapeutics.com

Email Address

Not Recorded

Overview

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eric Easom

        

Chief Financial Officer

Lucy Day

        

Chief Financial Officer

Paul Eckburg

        

Co-Founder

Michael Alley

        

Vice President

Vince Hernandez

        

VP - Bus. Development

Sanjay Chanda

        

VP - Manufacturing

Kieron Wesson

        

VP - Operations

Kevin Krause

        

Browse more venture capital transactions:

Prev: 11/26/2019: Capitolis venture capital transaction
Next: 11/26/2019: Copper Labs venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary